| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
333 |
301 |
$23K |
| 80053 |
Comprehensive metabolic panel |
1,133 |
983 |
$16K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
270 |
250 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
2,623 |
2,111 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
38 |
37 |
$5K |
| G0306 |
Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count |
880 |
758 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
405 |
339 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
42 |
41 |
$3K |
| 87428 |
|
122 |
112 |
$1K |
| 87486 |
|
42 |
41 |
$1K |
| 81002 |
|
45 |
40 |
$920.70 |
| 86140 |
|
118 |
95 |
$868.65 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
14 |
$860.30 |
| 84443 |
Thyroid stimulating hormone (TSH) |
65 |
54 |
$692.16 |
| 87581 |
|
42 |
41 |
$592.42 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
42 |
41 |
$305.12 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
12 |
$234.56 |
| 83735 |
|
52 |
46 |
$223.74 |
| 84439 |
|
30 |
29 |
$194.40 |
| 80061 |
Lipid panel |
16 |
15 |
$135.33 |
| 84481 |
|
30 |
29 |
$111.06 |
| 84479 |
|
15 |
13 |
$81.85 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
13 |
$63.41 |
| 85651 |
|
19 |
16 |
$14.64 |
| 85004 |
|
21 |
18 |
$0.00 |